The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company has โน502.07 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $โน504.16 B | -2.82% |
2023-12-31 | $โน518.80 B | 71.25% |
2022-12-31 | $โน302.94 B | -39.25% |
2021-12-31 | $โน498.68 B | -27.53% |
2020-12-31 | $โน688.11 B | -0.24% |
2019-12-31 | $โน689.79 B | -21.08% |
2018-12-31 | $โน874.03 B | -45.77% |
2017-12-31 | $โน1.611 T | -20.61% |
2016-12-31 | $โน2.030 T | 8.78% |
2015-12-31 | $โน1.866 T | 14.23% |
2014-12-31 | $โน1.633 T | 19.68% |
2013-12-31 | $โน1.365 T | 30.81% |
2012-12-31 | $โน1.043 T | 3.67% |
2011-12-31 | $โน1.006 T | -6.18% |
2010-12-31 | $โน1.072 T | 2.01% |
2009-12-31 | $โน1.051 T | 7.34% |
2008-12-31 | $โน979.85 B | 39.73% |
2007-12-31 | $โน701.26 B | -16.51% |
2006-12-31 | $โน839.91 B | -8.73% |
2005-12-31 | $โน920.29 B | 7.84% |
2004-12-31 | $โน853.38 B | -3.33% |
2003-12-31 | $โน882.78 B | 0.67% |
2002-12-31 | $โน876.89 B | 248.34% |
2001-12-31 | $โน251.73 B |